Event Date/Time: Oct 06, 2008 End Date/Time: Oct 07, 2008
Report as Spam


Drug repositioning efforts create alternative development routes for compounds that failed to meet their clinical endpoint but met safety milestones. Repositioning approaches can also be employed for existing drugs to identify alternative uses or new indications. This can involve screening a compound against new targets, or investigating a given target against new indications. Repurposing or repositioning represents both a faster and less risky route to development. A discussion of how to gain access to data, and overcome organizational boundaries will be covered. Case studies that best utilize available technologies to form a comprehensive picture of a compound or target’s potential value will be explored, and will shed light on how to exploit repositioning towards unmet medical need and expanding the drug pipeline.